GSE263012 LBR knockout K-562 Lamin Type A 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE263012_LBR knockout_K-562_Lamin Type A_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE263012_LBR knockout_K-562_Lamin Type A_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE263012_LBR knockout_K-562_Lamin Type A_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE263012_LBR knockout_K-562_Lamin Type A_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

valyl-tRNA synthetase 1

Gene

ribosomal protein S18

Gene

H3.3 histone A

Gene

Pvt1 oncogene

Gene

PAXX non-homologous end joining factor

Gene

CENPB DNA-binding domains containing 2, pseudogene

Gene

family with sequence similarity 27 member C

Gene

tripartite motif containing 10

Gene

MT-CO1 pseudogene 12

Gene

CCDC26 long non-coding RNA

  • Gene

    valyl-tRNA synthetase 1


  • Gene

    ribosomal protein S18




  • Gene

    PAXX non-homologous end joining factor


  • Gene

    CENPB DNA-binding domains containing 2, pseudogene


  • Gene

    family with sequence similarity 27 member C


  • Gene

    tripartite motif containing 10


  • Gene

    MT-CO1 pseudogene 12


  • Gene

    CCDC26 long non-coding RNA

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.